Saksoft Ltd
Q2 FY23 Earnings Call Analysis
IT - Software
fundraise: No informationcapex: Yesrevenue: Category 2margin: Category 2orderbook: No
💰fundraise
Any current/future new fundraising through debt or equity?
- Saksoft has not indicated any current fundraising through equity or debt.
- The acquisition of Solveda was funded entirely through internal accruals and if necessary, a little bit of debt.
- There is no mention of any planned equity issuance or significant new debt raising in the near future.
- The company emphasizes internal accruals for funding, showing a preference for self-funded growth.
- Management mentioned a mix of internal accruals and debt for acquisitions historically but did not specify new capital raising plans.
- Overall, there is no explicit current or future fundraising mentioned in the transcript.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- Saksoft is investing in its front-end sales force to increase presence and acquire new logos as well as scale existing ones.
- The company is investing in building capabilities to plan the next phase of growth.
- There is no specific mention of capital expenditure (capex) or capital investments in fixed assets in the transcript.
- The recent acquisition of Solveda, a software design and development company specializing in e-commerce applications, represents a strategic investment to expand into a niche market and enhance competitive advantage.
- The acquisition was funded through internal accruals without stock purchase or debt.
- Sustainability has been mentioned as a major goal, implying possible future investments aligned with green initiatives, though no specifics are provided.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Saksoft aims to reach $100 million in revenues by the end of the current financial year (FY23-24), including organic growth and acquisition contributions (e.g., Solveda).
- The company targets a year-on-year growth rate of 25% to 30% to achieve $500 million in revenues by 2030.
- While organic growth is expected, it may be slower than previous years due to current economic headwinds, especially in the US and Europe.
- Acquisition of Solveda, contributing around $6-$8 million, is expected to help achieve growth and expand market niches, particularly in the e-commerce B2B segment.
- Saksoft is investing in front-end salesforce strength to acquire new clients and scale existing ones.
- Despite a muted growth quarter, management remains confident in building a solid base for sustained future growth.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- Saksoft aims to reach $500 million in revenues by FY30, requiring a 25% to 30% year-on-year growth.
- For FY24, the target remains $100 million in revenue, combining organic and inorganic growth including the Solveda acquisition.
- Organic growth is expected but at a slower pace than last year due to headwinds like economic slowdown in the US and Europe.
- EBITDA margins are anticipated to improve, with focus on operational efficiencies and cost controls; current margin is around 18.8%.
- PAT margins target 14% to 15% for the year, with improvements expected going forward (currently at 13.7%).
- The Solveda acquisition is EBITDA accretive, expected to enhance combined EBITDA margins.
- Overall, management is confident in scaling growth and profitability through a combination of expanding client base, new verticals, and operational efficiencies despite temporary market challenges.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- The order book typically stands at 78% to 80% of the revenue targets and guidance for the financial year.
- For FY 2023-24, the guidance is close to $100 million, with the order book reflecting around 78%-80% of this target.
- With the acquisition of Solveda, the order book gets an additional boost due to Solveda's pending orders.
- The company maintains a generally consistent order book proportion relative to its revenue guidance each year.
